Xencor (XNCR) Other Non Operating Income (2013 - 2026)
Xencor's (XNCR) quarterly Other Non Operating Income came in at $396000.0 in Q1 2026, up 1377.42% year-on-year from $26803.5 in Q1 2025, and up 5050.0% on a QoQ basis from -$8000.0 in Q4 2025.
Xencor (XNCR) Other Non Operating Income (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of Other Non Operating Income data on file, last reported at $396000.0 in Q1 2026.
- On a quarterly basis, Other Non Operating Income rose 1377.42% year-over-year to $396000.0 in Q1 2026; TTM through Mar 2026 was $354000.0, a 1763.16% increase from a year earlier, with the FY2025 full-year figure at -$73000.0, down 246.0% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $396000.0, up from -$8000.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for XNCR reached as high as $1.4 million in Q4 2023 and fell as low as -$1.4 million in Q1 2023.
- Historically, Other Non Operating Income has averaged $3500.0 across 5 years, with a median of -$9500.0 in 2023.
- Across the five-year window, Other Non Operating Income sank 2350.0% in 2022 and soared 3347.62% in 2023, its largest moves.
- Year by year, Other Non Operating Income stood at -$42000.0 in 2022, then surged by 3347.62% to $1.4 million in 2023, then sank by 95.31% to $64000.0 in 2024, then sank by 112.5% to -$8000.0 in 2025, then jumped by 5050.0% to $396000.0 in 2026.
- Per Business Quant data, the three most recent Other Non Operating Income figures were $396000.0 in Q1 2026, -$8000.0 in Q4 2025, and -$17000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Xencor | 1.49 Bn | 1.11 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 396,000.00 |
| Dec 31, 2025 | -8,000.00 |
| Sep 30, 2025 | -17,000.00 |
| Jun 30, 2025 | -17,000.00 |
| Mar 31, 2025 | -31,000.00 |
| Dec 31, 2024 | 64,000.00 |
| Sep 30, 2024 | -10,000.00 |
| Jun 30, 2024 | -4,000.00 |
| Dec 31, 2023 | 1.36 Mn |
| Sep 30, 2023 | 6,000.00 |
| Jun 30, 2023 | -9,000.00 |
| Mar 31, 2023 | -1.39 Mn |
| Dec 31, 2022 | -42,000.00 |
| Sep 30, 2022 | -1,000.00 |
| Jun 30, 2022 | -147,000.00 |
| Mar 31, 2022 | -96,000.00 |
| Dec 31, 2021 | -664,000.00 |
| Sep 30, 2021 | -593,000.00 |
| Jun 30, 2021 | -6,000.00 |
| Mar 31, 2021 | -11,000.00 |